The University of Kansas Cancer Center -North — Kansas City, Missouri

The University of Kansas Cancer Center -North is a clinical research site located in Kansas City, Missouri, United States 64154.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center -North has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Myelodysplastic Syndrome, Acute Myeloid Leukemia.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center -North?

The University of Kansas Cancer Center -North has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center -North conducted?

The University of Kansas Cancer Center -North has 2 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Myelodysplastic Syndrome, Acute Myeloid Leukemia.

Is The University of Kansas Cancer Center -North accredited by Crixeo Health?

The University of Kansas Cancer Center -North has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center -North?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.